AN2 Therapeutics, Inc. Share Price
NASDAQ: ANTX | Micro CapAN2 Therapeutics, Inc. Stock Performance
AN2 Therapeutics, Inc. Share Price Today
As of 30 October 2026, AN2 Therapeutics, Inc.'s share price is $4.71. The stock opened at $4.57, compared to its previous close of $4.53. During today's trading session, AN2 Therapeutics, Inc.'s share price traded between $4.56 and $4.88, with an average price of $4.72. Over the past 52 weeks, the stock has recorded a high of $6.86 and a low of $1.01. In terms of performance, AN2 Therapeutics, Inc.'s share price has risen by 3.74% over the last six months and is up 289.26% on a year-on-year basis.
AN2 Therapeutics, Inc. Share Price Chart
AN2 Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
AN2 Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About AN2 Therapeutics, Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
AN2 Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.33 | $4.70 | -11.75% |
Sep 2026 | $5.67 | $5.32 | -7.07% |
Aug 2026 | $5.45 | $5.72 | +7.21% |
Jul 2026 | $4.95 | $5.34 | +10.56% |
Jun 2026 | $4.29 | $4.83 | +11.29% |
May 2026 | $4.50 | $4.34 | -4.41% |
Apr 2026 | $3.60 | $4.54 | +31.40% |
Mar 2026 | $1.08 | $3.46 | +215.53% |
Feb 2026 | $1.15 | $1.09 | -5.60% |
Jan 2026 | $1.09 | $1.16 | +6.42% |
Dec 2025 | $1.07 | $1.09 | +2.83% |
Nov 2025 | $1.19 | $1.06 | -12.40% |